The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 437-454

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility

By Levy Finn  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 8, 2013-08 ,pp. : 665-670

Springer Publishing Company

Access to resources Recommend Favorite

cGMP Inhibition of Endothelin-Stimulated Inositol Phosphate Production in the Fetal Lamb Pulmonary Artery

By Millard S.L.   Russell J.A.   Morin III F.C.   Adolf M.A.   Gugino S.F.   Steinhorn R.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 201-204

Academic Press

Access to resources Recommend Favorite

The new NO donor SPM3672 increases cGMP and improves contraction in rat cardiomyocytes and isolated heart

By Kojda G.   Brixius K.   Kottenberg K.   Nix P.   Schluter K.-D.   Piper H.M.   Noack E.  

European Journal of Pharmacology, Vol. 284, Iss. 3, 1995-09 ,pp. : 315-319

Elsevier

Access to resources Recommend Favorite

Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT₄ receptor activation in porcine left atrium

By Weninger Sabine   Maeyer Joris   Lefebvre Romain  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 8, 2013-08 ,pp. : 671-684

Springer Publishing Company

Access to resources Recommend Favorite